Paper7512751
Requirement of vascular integrin alpha v beta 3 for angiogenesis.
Brooks PC and 2 others. Science, 1994. Cited by 2,578 papers, by iCite.
Cite this record
ConductScience Library. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Papers, record 7512751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7512751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Granulation Tissue | Major topic |
| Integrins | Major topic |
| Neovascularization, Pathologic | Major topic |
| Receptors, Cytoadhesin | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Blood Vessels | |
| Chick Embryo | |
| Fibroblast Growth Factor 2 | |
| Humans | |
| Laminin | |
| Melanoma | |
| Receptors, Vitronectin | |
| Skin | |
| Tumor Necrosis Factor-alpha | |
| von Willebrand Factor |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA45726 | NCI NIH HHS | United States | R01CA045726 | PubMed and NIH | NIH RePORTER |
| CA50286 | NCI NIH HHS | United States | R01CA050286 | PubMed and NIH | NIH RePORTER |
| R37CA050286 | NIH | NIH RePORTER |
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01176500 | A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors | Background | ClinicalTrials.gov | |
| NCT01633255 | [18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment | Background | ClinicalTrials.gov | |
| NCT04871217 | 68Ga-NODAGA-RGD PET in Patients With an Occluded Coronary Artery | Background | ClinicalTrials.gov |
Cited by919
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,578 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42900344 | The interplay of integrin, VE-cadherin, and β-catenin signaling triad in angiogenesis: regulation by Wnt antagonist, secreted frizzled related protein 4 in the tumor angiogenic loop. | Med Oncol | 2026 | https://conductscience.org/library/papers/42900344 | PubMed |
| 42757471 | Integrin αVβ3 as a context‑dependent regulator of bone homeostasis: Insights into osteoporosis pathogenesis and therapeutic targeting (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42757471 | PubMed |
| 42592454 | Neutralizing dentin sialophosphoprotein facilitates tumor vascular normalization in colorectal cancer by blocking the crosstalk between tumor cells and endothelial cells. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42592454 | PubMed |
| 42416355 | Breaking the vicious cycle of impaired angiogenesis and chronic inflammation in diabetic wounds: a bioengineered microneedle system delivering RGD-modified M2 exosomes. | Burns Trauma | 2026 | https://conductscience.org/library/papers/42416355 | PubMed |
| 42243842 | Radionuclide‑drug conjugates in lung cancer: advances in precision therapy and clinical translation. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42243842 | PubMed |
| 42186350 | Application of Transgenic Silk Fibroin to Biomaterials. | Biotechnol Bioeng | 2026 | https://conductscience.org/library/papers/42186350 | PubMed |
| 42072707 | Galectin-3 Binds to the Allosteric Site and Activates Integrins αvβ3, αIIbβ3, and α5β1, and Lactose Inhibits This Activation. | Biomolecules | 2026 | https://conductscience.org/library/papers/42072707 | PubMed |
| 41961754 | Proteomic signatures of adipocyte recruitment in breast cancer. | Endocr Relat Cancer | 2026 | https://conductscience.org/library/papers/41961754 | PubMed |
| 41957669 | Oxidative stress induced by DMSA-IONPs impairs breast cancer cell migration and paracrine cell communication. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41957669 | PubMed |
| 41888978 | Reelin regulates the migration and differentiation of extravillous trophoblastic cells. | Biol Res | 2026 | https://conductscience.org/library/papers/41888978 | PubMed |
| 41849225 | The emerging role of integrin signaling in pulmonary vascular disease. | Am J Physiol Lung Cell Mol Physiol | 2026 | https://conductscience.org/library/papers/41849225 | PubMed |
| 41728292 | Acellular Adipose Tissue promotes anti-fibrotic remodeling in Phase II Study. | medRxiv | 2026 | https://conductscience.org/library/papers/41728292 | PubMed |
| 41676549 | Galectin-3 binds to the RGD-binding site in a glycan-independent manner and to the allosteric site and activates integrins αvβ3, αIIbβ3, and α5β1. | bioRxiv | 2026 | https://conductscience.org/library/papers/41676549 | PubMed |
| 41594872 | Corneal Neovascularization: Pathogenesis, Current Insights and Future Strategies. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/41594872 | PubMed |
| 41530428 | Angiogenesis PET/MRI predicts initial growth of sporadic vestibular schwannomas: a prospective study with follow-up in 29 patients using [68Ga]Ga-NODAGA-E[c(RGDyK)]2. | EJNMMI Res | 2026 | https://conductscience.org/library/papers/41530428 | PubMed |
| 41401976 | Beyond transcription: RNA-binding proteins steering angiogenesis. | Am J Physiol Heart Circ Physiol | 2026 | https://conductscience.org/library/papers/41401976 | PubMed |
| 41141979 | Overexpression of αVβ3 Integrin in an Aortic Aneurysm Murine Model: Confirmation in Ex Vivo Human Abdominal Aortic Aneurysm Tissue and Its Potential Application for Molecular Imaging Characterisation. | EJVES Vasc Forum | 2025 | https://conductscience.org/library/papers/41141979 | PubMed |
| 41049616 | Lactylation-Boosted m5C RNA Modification Drives Choroidal Neovascularization. | Research (Wash D C) | 2025 | https://conductscience.org/library/papers/41049616 | PubMed |
| 41017463 | Intramyocardial Hydrogel Delivery Decreases Left Ventricular Remodeling and Increases Angiogenesis Post Myocardial Infarction. | Circ Cardiovasc Imaging | 2025 | https://conductscience.org/library/papers/41017463 | PubMed |
| 40961140 | Endothelial αvβ3 integrin induction during hypoxia protects blood-brain barrier integrity. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40961140 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IGKV4-1 | 28908 | PubTator's text mining | https://conductscience.org/library/genes/28908 | NCBI Gene |
| ITGAV | 3685 | PubTator's text mining | https://conductscience.org/library/genes/3685 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7512751
GET https://conductscience.org/api/papers/v1/7512751/cited_by?page=2